| Patent | Date |
|---|
Fgf21 Variants
App 20220227825 - SOMMERFELD; Mark ; et al. | 2022-07-21 |
FGF21 variants
Grant 11,230,582 - Sommerfeld , et al. January 25, 2 | 2022-01-25 |
Expression And Folding In The Manufacturing Process Of Cd-rap By Using A Cd-rap Precursor Protein
App 20200268663 - SCHOETTLE; Isabell ; et al. | 2020-08-27 |
Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor protein
Grant 10,660,852 - Schoettle , et al. | 2020-05-26 |
Fusion Proteins For Treating A Metabolic Syndrome
App 20190085043 - Boscheinen; Oliver ; et al. | 2019-03-21 |
Improvement Of Expression And Folding In The Manufacturing Process Of Cd-rap By Using A Cd-rap Precursor Protein
App 20190046442 - SCHOETTLE; Isabell ; et al. | 2019-02-14 |
Fgf21 Variants
App 20180371041 - SOMMERFELD; Mark ; et al. | 2018-12-27 |
Pharmaceutical Composition For Treating A Metabolic Syndrome
App 20180236033 - Sommerfeld; Mark ; et al. | 2018-08-23 |
Insulin derivatives having an extremely delayed time-action profile
Grant 9,644,017 - Habermann , et al. May 9, 2 | 2017-05-09 |
Pharmaceutical Composition For Treating A Metabolic Syndrome
App 20160279199 - Sommerfeld; Mark ; et al. | 2016-09-29 |
Fusion proteins comprising FGF-21 and GLP-1R agonist
App 20160194371 - Boscheinen; Oliver ; et al. | 2016-07-07 |
Pharmaceutical Composition for Treating a Metabolic Syndrome
App 20150231210 - SOMMERFELD; Mark ; et al. | 2015-08-20 |
Method for amidating polypeptides with basic amino acid C-terminals by means of specific endoproteases
Grant 8,765,910 - Rissom , et al. July 1, 2 | 2014-07-01 |
Pharmaceutical Composition for Treating A Metabolic Syndrome
App 20140142023 - Sommerfeld; Mark ; et al. | 2014-05-22 |
Fusion Proteins For Treating A Metabolic Syndrome
App 20140073563 - BOSCHEINEN; Oliver ; et al. | 2014-03-13 |
Insulin derivatives having an extremely delayed time-action profile
Grant 8,633,156 - Habermann , et al. January 21, 2 | 2014-01-21 |
Pharmaceutical Composition For Treating A Metabolic Syndrome
App 20130203651 - Sommerfeld; Mark ; et al. | 2013-08-08 |
Method for producing insulin analogs having a dibasic B chain terminus
Grant 8,410,048 - Habermann , et al. April 2, 2 | 2013-04-02 |
Amidated insulin glargine
Grant 8,048,854 - Habermann , et al. November 1, 2 | 2011-11-01 |
Novel Insulin Derivatives Having An Extremely Delayed Time-action Profile
App 20110173722 - HABERMANN; Paul ; et al. | 2011-07-14 |
Method for producing carboxy-terminal-amidified peptides
Grant 7,939,293 - Habermann , et al. May 10, 2 | 2011-05-10 |
Novel Insulin Derivatives Having An Extremely Delayed Time-action Profile
App 20110077197 - HABERMANN; Paul ; et al. | 2011-03-31 |
Method For Amidating Polypeptides With Basic Amino Acid C-terminals By Means Of Specific Endoproteases
App 20100311112 - Rissom; Sebastian ; et al. | 2010-12-09 |
Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
Grant 7,638,618 - Habermann December 29, 2 | 2009-12-29 |
Method For Producing Insulin Analogs Having A Dibasic B Chain Terminus
App 20090192073 - HABERMANN; Paul ; et al. | 2009-07-30 |
Amidated Insulin Glargine
App 20090176692 - HABERMANN; Paul ; et al. | 2009-07-09 |
Method For Producing Carboxy-Terminal-Amidified Peptides
App 20090005299 - Habermann; Paul ; et al. | 2009-01-01 |
Signal sequences for preparing leu-hirudin by secretion by E. coli into the culture medium
Grant 7,455,987 - Habermann , et al. November 25, 2 | 2008-11-25 |
Fusion proteins capable of being secreted into a fermentation medium
Grant 7,202,059 - Habermann , et al. April 10, 2 | 2007-04-10 |
Mini-proinsulin, its preparation and use
Grant 6,875,589 - Dorschug , et al. April 5, 2 | 2005-04-05 |
Insulin analogs with enhanced zinc binding
Grant 6,686,177 - Ertl , et al. February 3, 2 | 2004-02-03 |
Nucleic acids, proteins, and processes thereof such as use of fusion proteins whose N-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
App 20030176673 - Habermann, Paul | 2003-09-18 |
C peptide for improved preparation of insulin and insulin analogs
Grant 6,534,288 - Habermann , et al. March 18, 2 | 2003-03-18 |
Nucleic acids, proteins, and processes for producing proteins such as fusion proteins for the secretion of a protein of interest into bacterial supernatants
App 20030044906 - Habermann, Paul ; et al. | 2003-03-06 |
Nucleic acids, proteins, and processes thereof such as processes for production of superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
App 20030028001 - Habermann, Paul | 2003-02-06 |
Bifunctional fusion proteins formed from hirudin and TAP
App 20020173620 - Habermann, Paul | 2002-11-21 |
Insulin derivatives having a rapid onset of action
Grant 6,221,633 - Ertl , et al. April 24, 2 | 2001-04-24 |
Secretion of hirudin derivatives
Grant 5,919,895 - Schmid , et al. July 6, 1 | 1999-07-06 |
Process for using the yeast ADH II promoter system for the production of heterologous proteins in high yields
Grant 5,866,371 - Badziong , et al. February 2, 1 | 1999-02-02 |
Synthetic isohirudins with improved stability
Grant 5,616,476 - Crause , et al. April 1, 1 | 1997-04-01 |
Fusion protein comprising an interleukin-2 fragment ballast portion
Grant 5,496,924 - Habermann , et al. March 5, 1 | 1996-03-05 |
Method of preparing fusion proteins
Grant 5,358,857 - Stengelin , et al. * October 25, 1 | 1994-10-25 |
Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
Grant 5,359,035 - Habermann October 25, 1 | 1994-10-25 |
GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
Grant 5,298,603 - Habermann , et al. March 29, 1 | 1994-03-29 |
Fusion proteins, their preparation and use
Grant 5,227,293 - Stengelin , et al. July 13, 1 | 1993-07-13 |
Process for the isolation and purification of hirudin
Grant 5,095,092 - Badziong , et al. March 10, 1 | 1992-03-10 |
| 